Pre-eclampsia
{{{Name|Pre-eclampsia}}}
[[Image:{{{Image}}}|190px|center|]] {{{Caption|}}}
|
| ICD-10
| {{ICD10
|
| ICD-O:
| {{{ICDO}}}
|
| ICD-9
| {{{ICD9}}}
|
| OMIM
| }}}
|
| MedlinePlus
| }}}
|
| eMedicine
| }}}
|
| DiseasesDB
| }}}
| , O13, O14|
ICD9 = 642.4-642.7|
ICDO = |
Image = |
Caption = |
OMIM = |
OMIM_mult = |
MedlinePlus = 000898 |
eMedicineSubj = med |
eMedicineTopic = 1905 |
DiseasesDB = 10494 |
}}
Pre-eclampsia (previously called toxemia) is a hypertensive disorder of pregnancy.
Inhaltsverzeichnis
- 1 Diagnosis
- 2 Appearance
- 3 Causes
- 4 Pathogenesis
- 5 Therapy
- 6 See also
- 7 Reference
|
Diagnosis
Pre-eclampsia is diagnosed when a pregnantwoman develops high blood pressure (two separate readings taken at least 6 hours apart of 140/90 or more) and 300 mg of protein in a 24 hour urine sample (proteinuria). Swelling or edema(especially in the hands and face) was originally considered an important sign for a diagnoses of pre-eclampsia, but in current medical practice only hypertension and proteinuria are necessary for a diagnoses.
Some women develop high blood pressure without the proteinuria, this is called Gestational Hypertension or, Pregnancy Induced Hypertension (PIH). Both Preeclampsia and PIH are very serious conditions and require careful monitoring of mother and baby.
Appearance
Pre-eclampsia is much more common in the first pregnancy (3-5% of births) and usually becomes evident in the third trimester(and virtually always after the 20th week of pregnancy). It is also more common in women who have preexisting hypertension, diabetes, or renal disease, in women with a family history of pre-eclampsia, and in women with a multiple gestation (twins, tripletsand more).
Pre-eclampsia may also occur in the immediate post-partum period or up to 6-8 weeks post-partum. This is referred to as "post partum pre-eclampsia".
Causes
Pre-eclampsia is thought to be caused by inflammatorymediators secreted by the placentaand acting on the vascular endothelium. If severe, it progresses to fulminant pre-eclampsia, with headachesand visual disturbances, and further to HELLP syndromeand eclampsia. These are life-threatening conditionsfor both the developing fetus and the mother.
Pathogenesis
There are many theories on the pathogenesis of preeclampsia, although the exact cause is not known. Most involve abnormal development of the placenta, which leads to a distressed placenta that secretes factors into the maternal blood. These factors damage the maternal blood vessels, leading to high blood pressure and protein in the urine.
In normal placenta the decidualspiral arteries are invaded by extravillous trophoblastswhich makes the arteies eventually open into trophoblastic cavities called lacunae (though they are initially kept plugged by the trophoblasts). The invading trophoblasts replace some of the smooth musclesand endotheliumof these arteries near the implantation site. This is supposed to help the spiral arteries to widen into thin and funnel like near their opening into the lacunae. This establishes a high capacity and low resistance circulation. The maternal blood in the lacunar network bath the chorionic villi lined by syncytiotrophoblast, supplying oxygen and nutrients to, and removing metabolic wastes from, the fetal circulation which is not in direct contact with the maternal blood. In case of preeclampsia the spiral arteries are insufficiently invaded by trophoblasts. They remain narrow and the smooth mucle layer (tunica media) around the arteries become hyperplastic. This leads to insufficient maternal perfusion of the placenta in preeclampsia. One of the factors, released into blood from the placenta, that has been speculated (by Karumanchi et al) to be a mediator of the "toxemia", is a soluble splice variant isoform of the VEGF receptor 1 (sFlt 1).
Therapy
The most successful treatment for eclampsia or advancing preeclampsia is delivery, either by inductionor Caesarean section. Some forms of preeclampsia can be treated with anti-hypertensive medication. In some cases women with preeclampsia or eclampsia can be stabilized temporarily with magnesium sulfateintravenously to prevent seizures. Attempts will be made to delay delivery until the fetus has matured, but in severe cases where the mother's life is threatened, delivery must occur as soon as possible.
See also
- Pregnancy-induced hypertension
- Eclampsia
- Hypomagnesemia
Reference
- GPnotebook395968546de:Präeklampsie
es:Pre-eclampsia
fr:Pré-éclampsie
nl:Pre-eclampsie
Categories: Medical emergencies| Obstetrics| Pregnancy
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article Pre-eclampsia.
|